Prognostic Power of Detecting Minimal Residual Disease in Ovarian Cancer
Minimal residual disease (MRD) is a major barrier to curing advanced ovarian cancer, even in patients who appear disease-free after initial therapy. A recent study of 95 patients showed that MRD detected through second-look laparoscopy or circulating tumor DNA strongly predicted shorter progression-free and overall survival.